Summary
Introduction
The Canadian pharmaceutical market is the 8th largest globally and as such represents an important market for generics manufacturers. Although historically dominated by domestic generics companies, mergers and acquisitions over the last five years have increased the dominance of foreign players.
Scope
- Overview of the size of the Canadian generics market
- Assessment of the key drivers and resistors affecting the Canadian generics market
- Profiles of the leading companies in the Canadian generics market
Highlights
The Canadian generics sector has recorded steady growth over recent years to become one of the more mature generics markets compared to the other major pharmaceutical markets. However a number of issues impacting the market make it a very different operating environment compared to the neighboring US market.
Domestic generics manufacturers have historically had an advantage in this market however overseas players have increased there presence through acquisitions over recent years to enable them to benefit from the same advantages.
Reasons to Purchase
- Assess the size of the Canadian generics market relative to the other major markets globally
- Examine the growth drivers and resistors that are shaping this significant generics market
- Benchmark the key companies operating in the Canadian generics market
|
